Results 81 to 90 of about 5,631,965 (202)
Von Hippel-Lindau (VHL) syndrome is a familial cancer syndrome caused by mutations in the tumor suppressor gene VHL. We generated human iPSC lines from primary dermal fibroblasts of three VHL syndrome patients carrying distinct VHL germ line mutations (c.
Jens Schuster +5 more
doaj +1 more source
von Hippel-Lindau disease manifesting as a chiasmal syndrome
A 21-year-old woman presented with a two year history of progressive loss of vision in the left eye. Brain MRI revealed a supresellar mass felt to be most consistent with a meningioma. However, pathologic examination including special stains disclosed features characteristic of hemangioblastoma.
Jonathan Wirtschafter +5 more
openaire +2 more sources
Von Hippel Lindau lesion on optic disc showing minimal increase in size over three year interval. Anatomy: Optic disc. Pathology: Hemangioblastoma. Disease/Diagnosis: Von Hippel Lindau disease. Clinical: Patient other eye was removed for hemangioblastoma.
William F. Hoyt, MD
core
Von Hippel-Lindau disease (VHLD)
Von Hippel-Lindau disease is one the 7000 known hereditary disorder. It is named after Dr. Eugen von Hippel; a German ophthalmologist who was the first to described the ocular angiomas in 1895. Equally, Dr. Arvid Lindau, a Swedish pathologist, begins the
Jorge Luis González Jara
doaj
Von Hippel Lindau Disease. Retinal photograph showing small whitish hemangiomablastoma. Note the dilated arterial and venous channels entering and leaving the tumor. Anatomy: Retina. Pathology: Hemangioblastoma.
William F. Hoyt, MD
core
Von Hippel-Lindau disease with extramedullary and pancreatic involvement
We report a patient with Von Hippel-Lindau disease who presented with an intradural extramedullary hemangioblastoma as a primary manifestation.Revisión por ...
Murillo-Díaz, Giuliana +3 more
core +1 more source
Genetic linkage analysis of von hippel-lindau disease
Genetik, von Hippel-Lindau, kromosom nr 3 ...
Sampson, J.S. +21 more
core +1 more source
Von Hippel Lindau syndrome: A systematic review of pharmaceutical treatments
Background Patients with von Hippel-Lindau syndrome (VHL) have an increased risk of developing multiple neoplasms. Recently, multiple pharmacologic interventions have been assessed for the treatment of these VHL-associated neoplasms.
Gliceida M Galarza Fortuna +5 more
doaj +1 more source
Von Hippel Lindau Disease (Retinal Hemangioblastoma)
Von Hippel Lindau Disease with large retinal hemangioblastoma. Continued view of the arteriole and venous channels leading to the tumor. Group with R1_C3a, R1_C3c, R1_C3d. Anatomy: Retina. Pathology: Hemangioblastoma. Disease/Diagnosis: Von Hippel Lindau
William F. Hoyt, MD
core
Somatic Mosaicism in von Hippel-Lindau Disease
von Hippel-Lindau (VHL) disease is an autosomal dominant familial cancer syndrome predisposing to the development of retinal and central nervous system haemangioblastomas, pheochromocytomas, renal and pancreatic cancer.
MARTELLA, MADDALENA +5 more
core +1 more source

